Nifedipine tablets are manufactured by several pharmaceutical companies, indicating a competitive market for this medication.
Who is Currently Making Nifedipine Tablets?
Companies that manufacture nifedipine tablets include Amneal Pharmaceuticals, Aurobindo Pharma, Blue Cross Laboratories, Bristol-Myers Squibb, Granules India, Lannett Company, Mylan, Novartis, Orchid Chemicals & Pharmaceuticals, Pfizer, Ranbaxy Laboratories, Salix Pharmaceuticals, Sun Pharmaceutical Industries, and Teva Pharmaceutical Industries [1].
What is Nifedipine Used For?
Nifedipine is a calcium channel blocker used to treat high blood pressure and angina (chest pain) [2]. It works by relaxing blood vessels, which lowers blood pressure and reduces the workload on the heart [2].
When Does Nifedipine Patent Exclusivity End?
Patent expiration dates are crucial for understanding when generic versions of a drug can enter the market. Information on specific patent expiries for nifedipine formulations can be found through resources like DrugPatentWatch.com, which tracks patent and exclusivity data for pharmaceutical products [3].
How Do Different Nifedipine Formulations Work?
Nifedipine is available in various formulations, including immediate-release and extended-release tablets. Immediate-release tablets are typically taken two to four times a day, while extended-release formulations allow for once or twice-daily dosing [4]. The extended-release versions are designed to release the medication slowly over time, providing a more consistent blood pressure control and reducing the frequency of dosing [4]. This difference in release mechanisms can affect how the drug is used and its therapeutic outcomes.